Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Laruelle, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 107 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laruelle, M; Huang, Y
      Vulnerability of Positron Emission Tomography radiotracers to endogenous competition - New insights

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    2. Slifstein, M; Laruelle, M
      Models and methods for derivation of in vivo neuroreceptor parameters withPET and SPECT reversible radiotracers

      NUCLEAR MEDICINE AND BIOLOGY
    3. Huang, YY; Kegeles, LS; Bae, SA; Hwang, DR; Roth, BL; Savage, JE; Laruelle, M
      Synthesis of potent and selective dopamine D-4 antagonists as candidate radioligands

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Martinez, D; Gelernter, J; Abi-Dargham, A; van Dyck, CH; Kegeles, L; Innis, RB; Laruelle, M
      The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporterphenotype in humans

      NEUROPSYCHOPHARMACOLOGY
    5. Martinez, D; Hwang, DR; Mawlawi, O; Slifstein, M; Kent, J; Simpson, N; Parsey, RV; Hashimoto, T; Huang, YY; Shinn, A; Van Heertum, R; Abi-Dargham, A; Caltabiano, S; Malizia, A; Cowley, H; Mann, JJ; Laruelle, M
      Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: A dose-occupancy study with [C-11]WAY 100635 and positron emission tomography in humans

      NEUROPSYCHOPHARMACOLOGY
    6. Mawlawi, O; Martinez, D; Slifstein, M; Broft, A; Chatterjee, R; Hwang, DR; Huang, YY; Simpson, N; Ngo, K; Van Heertum, R; Laruelle, M
      Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D-2 receptor parameter measurements inventral striatum

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    7. Parsey, RV; Oquendo, MA; Zea-Ponce, Y; Rodenhiser, J; Kegeles, LS; Pratap, M; Cooper, TB; Van Heertum, R; Mann, JJ; Laruelle, M
      Dopamine D-2 receptor availability and amphetamine-induced dopamine release in unipolar depression

      BIOLOGICAL PSYCHIATRY
    8. Kegeles, LS; Laruelle, M; Carlsson, A
      Ketamine has equal affinity for NMDA receptors and the high-affinity stateof the dopamine D-2 receptor - Reply

      BIOLOGICAL PSYCHIATRY
    9. Schneier, FR; Liebowitz, MR; Laruelle, M
      Detachment and generalized social phobia

      AMERICAN JOURNAL OF PSYCHIATRY
    10. Artigas, F; Celada, P; Laruelle, M; Adell, A
      How does pindolol improve antidepressant action?

      TRENDS IN PHARMACOLOGICAL SCIENCES
    11. Lombardo, I; Abi-Dargham, A; Kegeles, L; Laruelle, M
      "Functional" neuroreceptor imaging - The example of studies of synaptic dopamine activity with single photon emission computed tomography

      PSYCHIATRIC NEUROIMAGING RESEARCH: CONTEMPORARY STRATEGIES
    12. Laruelle, M
      The role of model-based methods in the development of single scan techniques

      NUCLEAR MEDICINE AND BIOLOGY
    13. Hwang, DR; Kegeles, LS; Laruelle, M
      (-)-N-[C-11]propyl-norapomorphine: A positron-labeled dopamine agonist forPET imaging of D-2 receptors

      NUCLEAR MEDICINE AND BIOLOGY
    14. Slifstein, M; Parsey, RV; Laruelle, M
      Derivation of [C-11]WAY-100635 binding parameters with reference tissue models: Effect of violations of model assumptions

      NUCLEAR MEDICINE AND BIOLOGY
    15. Martinez, D; Mawlawi, O; Hwang, DR; Kent, J; Simpson, N; Parsey, RV; Hashimoto, T; Slifstein, M; Huang, YY; Van Heertum, R; Abi-Dargham, A; Caltabiano, S; Malizia, A; Cowley, H; Mann, JJ; Laruelle, M
      Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: Preliminary analyses

      NUCLEAR MEDICINE AND BIOLOGY
    16. Scanley, BE; Gandelman, MS; Laruelle, M; Al-Tikriti, MS; Baldwin, RM; Zoghbi, SS; Hoffer, PB; Wang, S; Neumeyer, JL; Innis, RB
      [I-123]IPCIT and [I-123]beta-CIT as SPECT tracers for the dopamine transporter: A comparative analysis in nonhuman primates

      NUCLEAR MEDICINE AND BIOLOGY
    17. Kegeles, LS; Shungu, DC; Anjilvel, S; Chan, S; Ellis, SP; Xanthopoulos, E; Malaspina, D; Gorman, JM; Mann, JJ; Laruelle, M; Kaufmann, CA
      Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies

      PSYCHIATRY RESEARCH-NEUROIMAGING
    18. Parsey, RV; Slifstein, M; Hwang, DR; Abi-Dargham, A; Simpson, N; Mawlawi, O; Guo, NN; Van Heertum, R; Mann, JJ; Laruelle, M
      Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-C-11]WAY-100635 in humans: Comparison of arterial and reference tissue input functions

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    19. Laruelle, M
      Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    20. Abi-Dargham, A; Martinez, D; Mawlawi, O; Simpson, N; Hwang, DR; Slifstein, M; Anjilvel, S; Pidcock, J; Guo, NN; Lombardo, I; Mann, JJ; Van Heertum, R; Foged, C; Halldin, C; Laruelle, M
      Measurement of striatal and extrastriatal dopamine D-1 receptor binding potential with [C-11]NNC 112 in humans: Validation and reproducibility

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    21. van Dyck, CH; Malison, RT; Seibyl, JP; Laruelle, M; Klumpp, H; Zoghbi, SS; Baldwin, RM; Innis, RB
      Age-related decline in central serotonin transporter availability with [I-123]beta-CIT SPECT

      NEUROBIOLOGY OF AGING
    22. Laruelle, M
      The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

      BRAIN RESEARCH REVIEWS
    23. Parsey, RV; Kegeles, LS; Hwang, DR; Simpson, N; Abi-Dargham, A; Mawlawi, O; Slifstein, M; Van Heertum, RL; Mann, JJ; Laruelle, M
      In vivo quantification of brain serotonin transporters in humans using [C-11]McN 5652

      JOURNAL OF NUCLEAR MEDICINE
    24. Slifstein, M; Laruelle, M
      Effects of statistical noise on graphic analysis of PET neuroreceptor studies

      JOURNAL OF NUCLEAR MEDICINE
    25. Abi-Dargham, A; Rodenhiser, J; Printz, D; Zea-Ponce, Y; Gil, R; Kegeles, LS; Weiss, R; Cooper, TB; Mann, JJ; Van Heertum, RL; Gorman, JM; Laruelle, M
      Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    26. Martinez, D; Broft, A; Laruelle, M
      Pindolol augmentation of antidepressant treatment: Recent contributions from brain imaging studies

      BIOLOGICAL PSYCHIATRY
    27. Kegeles, LS; Abi-Dargham, A; Zea-Ponce, Y; Rodenhiser-Hill, J; Mann, JJ; Van Heertum, RL; Cooper, TB; Carlsson, A; Laruelle, M
      Modulation of amphetamine-induced striatal dopamine release by ketamine inhumans: Implications for schizophrenia

      BIOLOGICAL PSYCHIATRY
    28. Laruelle, M; Abi-Dargham, A; van Dyck, C; Gil, R; D'Souza, DC; Krystal, J; Seibyl, J; Baldwin, R; Innis, R
      Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [I-123]beta-CIT

      BIOLOGICAL PSYCHIATRY
    29. Schneier, FR; Liebowitz, MR; Abi-Dargham, A; Zea-Ponce, Y; Lin, SH; Laruelle, M
      Low dopamine D-2 receptor binding potential in social phobia

      AMERICAN JOURNAL OF PSYCHIATRY
    30. Zea-Ponce, Y; Laruelle, M
      Protein precipitation: An expedient procedure for the routine analysis of the plasma metabolites of [I-123]IBZM

      NUCLEAR MEDICINE AND BIOLOGY
    31. Hwang, DR; Simpson, NR; Montoya, J; Mann, JJ; Laruelle, M
      An improved one-pot procedure for the preparation of [C-11-carbonyl]-WAY100635

      NUCLEAR MEDICINE AND BIOLOGY
    32. Zea-Ponce, Y; Laruelle, M
      Synthesis of [I-123]IBZM: A reliable procedure for routine clinical studies

      NUCLEAR MEDICINE AND BIOLOGY
    33. Abi-Dargham, A; Laruelle, M; Krystal, J; D'Souza, C; Zoghbi, S; Baldwin, RM; Seibyl, J; Mawlawi, O; de Erasquin, G; Charney, D; Innis, RB
      No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    34. Abi-Dargham, A; Simpson, N; Kegeles, L; Parsey, R; Hwang, DR; Anjilvel, S; Zea-Ponce, Y; Lombardo, I; Van Heertum, R; Mann, JJ; Foged, C; Halldin, C; Laruelle, M
      PET studies of binding competition between endogenous dopamine and the D-1radiotracer [C-11]NNC 756

      SYNAPSE
    35. Kegeles, LS; Zea-Ponce, Y; Abi-Dargham, A; Rodenhiser, J; Wang, T; Weiss, R; Van Heertum, RL; Mann, JJ; Laruelle, M
      Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans

      SYNAPSE
    36. Laruelle, M
      Modelling: when and why?

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    37. Laruelle, M; Abi-Dargham, P
      Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

      JOURNAL OF PSYCHOPHARMACOLOGY
    38. Laruelle, M; Abi-Dargham, A; Gil, R; Kegeles, L; Innis, R
      Increased dopamine transmission in schizophrenia: Relationship to illness phases

      BIOLOGICAL PSYCHIATRY
    39. Gurguis, GNM; Turkka, J; Laruelle, M; Kleinman, J; Linnoila, M
      Coupling efficiency of brain beta-adrenergic receptors to G(s) protein in suicide, alcoholism and control subjects

      PSYCHOPHARMACOLOGY
    40. LARUELLE M; GELERNTER J; INNIS RB
      D-2 RECEPTORS BINDING POTENTIAL IS NOT AFFECTED BY TAQ1 POLYMORPHISM AT THE D-2 RECEPTOR GENE

      Molecular psychiatry
    41. Laruelle, M
      Imaging dopamine transmission in schizophrenia

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    42. MALISON RT; INNIS RB; LARUELLE M
      RE - LOGAN ET-AL., 1997

      Synapse
    43. ABIDARGHAM A; SIMPSON N; KEGELES L; PARSEY R; HWANG DR; ANJILVEL S; ZEAPONCE Y; LOMBARDO I; VANHEERTUM R; FOGED C; HALLDIN C; LARUELLE M
      PET STUDIES OF BINDING COMPETITION BETWEEN ENDOGENOUS DOPAMINE AND THE D-1 RADIOTRACER [C-11] NNC-756

      The Journal of nuclear medicine
    44. ABIDARGHAM A; PRINTZ D; KEGELES L; RODENHISER J; ZEAPONCE Y; WEISS R; POZNIAKOFF T; GERMAN J; VANHEERTUM R; LARUELLE M
      SPECT IMAGING OF RESTING DOPAMINE SYNAPTIC RELEASE IN THE STRIATUM OFUNTREATED SCHIZOPHRENIC-PATIENTS

      The Journal of nuclear medicine
    45. PARSEY RV; HWANG D; SIMPSON N; KEGELES L; ANJIVEL S; ZEAPONCE Y; LOMBARDO I; POPILSKIS S; VANHEERTUM R; MANN JJ; LARUELLE M
      KINETIC DERIVATION OF SEROTONIN 5HT-1A RECEPTOR-BINDING POTENTIAL WITH [C-11] CARBONYL-WAY-100635 AND COMPETITION STUDIES WITH ENDOGENOUS SEROTONIN

      The Journal of nuclear medicine
    46. KEGELES L; ZEAPONCE Y; ABIDARGHAM A; RODENHISER J; WANG T; KEILP J; WEISS R; COOPER TB; VANHEERTUM R; LARUELLE M
      REPRODUCIBILITY OF SPECT MEASUREMENT OF STRIATAL AMPHETAMINE-INDUCED DOPAMINE RELEASE IN HEALTHY-SUBJECTS

      The Journal of nuclear medicine
    47. KAPUR S; SEEMAN P; JOYCE J; LARUELLE M; BREIER A
      THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - ALIVE, WELL AND MOVING AHEAD

      Biological psychiatry
    48. ABIDARGHAM A; GIL R; KRYSTAL J; BALDWIN RM; SEIBYL JP; BOWERS M; VANDYCK CH; CHARNEY DS; INNIS RB; LARUELLE M
      INCREASED STRIATAL DOPAMINE TRANSMISSION IN SCHIZOPHRENIA - CONFIRMATION IN A 2ND COHORT

      The American journal of psychiatry
    49. MALISON RT; BEST SE; VANDYCK CH; MCCANCE EF; WALLACE EA; LARUELLE M; BALDWIN RM; SEIBYL JP; PRICE LH; KOSTEN TR; INNIS RB
      ELEVATED STRIATAL DOPAMINE TRANSPORTERS DURING ACUTE COCAINE ABSTINENCE AS MEASURED BY [I-123] BETA-CIT SPECT

      The American journal of psychiatry
    50. ABIDARGHAM A; KRYSTAL JH; ANJILVEL S; SCANLEY BE; ZOGHBI S; BALDWIN RM; RAJEEVAN N; ELLIS S; PETRAKIS IL; SEIBYL JP; CHARNEY DS; LARUELLE M; INNIS RB
      ALTERATIONS OF BENZODIAZEPINE RECEPTORS IN TYPE-II ALCOHOLIC SUBJECTSMEASURED WITH SPECT AND [I-123] IOMAZENIL

      The American journal of psychiatry
    51. ABIDARGHAM A; KEGELES L; MALASPINA D; CLARK S; GORMAN J; MANN J; VANHEERTUM R; LARUELLE M
      SPECT MEASUREMENT OF HUMAN STRIATAL SYNAPTIC DOPAMINE CONCENTRATION WITH [I-123] IBZM

      Schizophrenia research
    52. LARUELLE M; ABIDARGHAM A; KRYSTAL JH; CHARNEY DS; INNIS RB
      IN-VIVO EVALUATION OF DOPAMINE SYNAPTIC FUNCTION IN UNTREATED SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    53. ABIDARGHAM A; LARUELLE M; AGHAJANIAN GK; CHARNEY D; KRYSTAL J
      THE ROLE OF SEROTONIN IN THE PATHOPHYSIOLOGY AND TREATMENT OF SCHIZOPHRENIA

      The Journal of neuropsychiatry and clinical neurosciences
    54. LARUELLE M; DSOUZA CD; BALDWIN RM; ABIDARGHAM A; KANES SJ; FINGADO CL; SEIBYL JP; ZOGHBI SS; BOWERS MB; JATLOW P; CHARNEY DS; INNIS RB
      IMAGING D-2 RECEPTOR OCCUPANCY BY ENDOGENOUS DOPAMINE IN HUMANS

      Neuropsychopharmacology
    55. LARUELLE M; IYER RN; ALTIKRITI MS; ZEAPONCE Y; MALISON R; ZOGHBI SS; BALDWIN RM; KUNG HF; CHARNEY DS; HOFFER PB; INNIS RB; BRADBERRY CW
      MICRODIALYSIS AND SPECT MEASUREMENTS OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN NONHUMAN-PRIMATES

      Synapse
    56. BRAUN AR; LARUELLE M; MOURADIAN MM
      INTERACTIONS BETWEEN D1 AND D2 DOPAMINE-RECEPTOR FAMILY AGONISTS AND ANTAGONISTS - THE EFFECTS OF CHRONIC EXPOSURE ON BEHAVIOR AND RECEPTOR-BINDING IN RATS AND THEIR CLINICAL IMPLICATIONS

      Journal of neural transmission
    57. SUEHIRO M; UNDERWOOD M; YATABE T; PRATAP M; MANN JJ; LARUELLE M
      RADIOSYNTHESIS AND BIODISTRIBUTION OF [C-11] LY274601, A 5-HT1A RECEPTOR AGONIST

      The Journal of nuclear medicine
    58. LARUELLE M; ABIDARGHAM A; GIL R; KRYSTAL J; SEIBYL J; BALDWIN R; INNIS RB
      IMPACT OF THE CHOICE OF OUTCOME MEASURE ON THE SPECT MEASUREMENT OF D2 RECEPTORS IN SCHIZOPHRENIA

      The Journal of nuclear medicine
    59. KEGELES L; SUEHIRO M; ZEAPONCE Y; POPILSKIS S; ANJILVEL S; ESSER P; VANHEERTUM R; MANN JJ; LARUELLE M
      QUANTIFICATION OF 5-HT TRANSPORTER BINDING POTENTIAL WITH (-11] AND (-)[C-11] MCN-5652()[C)

      The Journal of nuclear medicine
    60. ABIDARGHAM A; ZEAPONCE Y; TERRIER D; ALTIKRITI M; BALDWIN RM; HOFFER P; CHARNEY D; LEYSEN JE; LARUELLE M; MERTENS J; INNIS RB
      PRECLINICAL EVALUATION OF [I-123] R93274 AS A SPECT RADIOTRACER FOR IMAGING 5-HT2A RECEPTORS

      European journal of pharmacology
    61. LARUELLE M; ABIDARGHAM A; GIL R; VANDYCK CH; ERDOS J; DSOUZA D; ROSENBLATT W; MCCANCEKATZ E; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; HOFFER PB; KRYSTAL J; CHARNEY DS; INNIS RB
      SPECT IMAGING OF SYNAPTIC DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS - AN EXPERIMENTAL VALIDATION OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA

      Schizophrenia research
    62. ABIDARGHAM A; GANDELMAN MS; DEERAUSQUIN GA; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; LARUELLE M; CHARNEY DS; HOFFER PB; NEUMEYER JL; INNIS RB
      SPECT IMAGING OF DOPAMINE TRANSPORTERS IN HUMAN BRAIN WITH IODINE-123-FLUOROALKYL ANALOGS OF BETA-CIT

      The Journal of nuclear medicine
    63. LARUELLE M; DSOUZA CD; ZOGHBI SS; BALDWIN RM; CHARNEY DS; INNIS RB
      SPECT MEASUREMENT OF DOPAMINE SYNAPTIC CONCENTRATION IN THE RESTING STATE

      The Journal of nuclear medicine
    64. LARUELLE M; ABIDARGHAM A; GIL R; ERDOS J; DSOUZA CD; ZOGHBI SS; BALDWIN RM; SEIBYL JP; KRYSTAL J; CHARNEY DS; INNIS RB
      SPECT MEASUREMENT OF DOPAMINE TRANSPORTERS IN SCHIZOPHRENIA

      The Journal of nuclear medicine
    65. LARUELLE M; VANDYCK CH; ABIDARGHAM A; ROSENBLATT W; ZOGHBI SS; BALDWIN RM; HOFFER PB; CHARNEY DS; INNIS RB
      AGE-RELATED DECLINE IN AMPHETAMINE-INDUCED DOPAMINE RELEASE MEASURED WITH SPECT AND [123I]IBZM IN HEALTHY-SUBJECTS

      The Journal of nuclear medicine
    66. VANDYCK CH; SEIBYL JP; LARUELLE M; BEST S; SHEFF K; MAREK KL; MALISON RT; ZOGHBI SS; ZEAPONCE Y; BALDWIN RM; CHARNEY DS; HOFFER PB; INNIS RB
      AGING EFFECTS WITH [I-123] BETA-CIT SPECT - ANALYSIS OF GENDER, STRIATAL SUBREGION, AND NEUROPSYCHOLOGICAL CORRELATES

      The Journal of nuclear medicine
    67. ABIDARGHAM A; KRYSTAL J; WEBB E; ZOGHBI S; LARUELLE M; PETRAKIS I; BALDWIN RM; HOFFER PB; CHARNEY DS; INNIS RB
      SPECT IMAGING OF BENZODIAZEPINE RECEPTORS IN ALCOHOLICS AND HEALTHY CONTROLS

      The Journal of nuclear medicine
    68. SEIBYL JP; LARUELLE M; VANDYCK CH; WALLACE E; BALDWIN RM; ZOGHBI S; ZEAPONCE Y; NEUMEYER JL; CHARNEY DS; HOFFER PB; INNIS RB
      REPRODUCIBILITY OF IODINE-123-BETA-CIT SPECT BRAIN MEASUREMENT OF DOPAMINE TRANSPORTERS

      The Journal of nuclear medicine
    69. LARUELLE M; ABIDARGHAM A; VANDYCK CH; GIL R; DSOUZA CD; ERDOS J; MCCANCE E; ROSENBLATT W; FINGADO C; ZOGHBI SS; BALDWIN RM; SEIBYL JP; KRYSTAL JH; CHARNEY DS; INNIS RB
      SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY IMAGING OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC SUBJECTS

      Proceedings of the National Academy of Sciences of the United Statesof America
    70. ABIDARGHAM A; LARUELLE M; CHARNEY D; KRYSTAL J
      SEROTONIN AND SCHIZOPHRENIA - A REVIEW

      Medicamentos de actualidad
    71. LARUELLE M; ABIDARGHAM A; VANDYCK CH; KRYSTAL JH; CHARNEY DS; INNIS RB
      INCREASED STRIATAL DOPAMINE RELEASE IN DRUG-FREE SCHIZOPHRENIC SUBJECTS

      Biological psychiatry
    72. LARUELLE M; INNIS RB
      NEUROIMAGING .13. SPECT IMAGING OF SYNAPTIC DOPAMINE

      The American journal of psychiatry
    73. ALTIKRITI MS; ZEAPONCE Y; BALDWIN RM; ZOGHBI SS; LARUELLE M; SEIBYL JP; GIDDINGS SS; SCANLEY BE; CHARNEY DS; HOFFER PB; SPARKS R; STUBBS J; WANG SY; NEUMEYER JL; INNIS RB
      CHARACTERIZATION OF THE DOPAMINE TRANSPORTER IN NONHUMAN PRIMATE BRAIN - HOMOGENATE BINDING, WHOLE-BODY IMAGING, AND EX-VIVO AUTORADIOGRAPHY USING [I-125]IPCIT AND [I-123]IPCIT

      Nuclear medicine and biology
    74. ABIDARGHAM A; KRYSTAL J; LARUELLE M; DSOUZA D; ZOGHBI S; BRENNER L; GIL R; SERNYAK M; BALDWIN RM; ZUBAL G; HOFFER PB; CHARNEY DS; INNIS RB
      SPECT IMAGING OF THE BENZODIAZEPINE RECEPTOR IN SCHIZOPHRENICS AND HEALTHY-SUBJECTS

      Schizophrenia research
    75. LARUELLE M; ABIDARGHAM A; VANDYCK CH; ROSENBLATT W; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; CHARNEY DS; HOFFER PB; KING HF; INNIS RB
      SPECT IMAGING OF STRIATAL DOPAMINE RELEASE AFTER AMPHETAMINE CHALLENGE IN HUMANS - RELATIONSHIP BETWEEN SUBJECTIVE EFFECTS AND DOPAMINE RELEASE

      Schizophrenia research
    76. SCANLEY BE; ALTIKRITI MS; GANDELMAN MS; LARUELLE M; ZEAPONCE Y; BALDWIN RM; ZOGHBI SS; HOFFER PB; CHARNEY DS; WANG SY; NEUMEYER JL; INNIS RB
      COMPARISON OF [I-123] BETA-CIT AND [I-123] IPCIT AS SINGLE-PHOTON EMISSION TOMOGRAPHY RADIOTRACERS FOR THE DOPAMINE TRANSPORTER IN NONHUMAN-PRIMATES

      European journal of nuclear medicine
    77. VANDYCK CH; SEIBYL JP; MALISON RT; LARUELLE M; WALLACE E; ZOGHBI SS; ZEAPONCE Y; BALDWIN RM; CHARNEY DS; HOFFER PB; INNIS RB
      AGE-RELATED DECLINE IN STRIATAL DOPAMINE TRANSPORTER BINDING WITH IODINE-123-BETA-CIT SPECT

      The Journal of nuclear medicine
    78. LARUELLE M; ABIDARGHAM A; VANDYCK CH; ROSENBLATT W; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; CHARNEY DS; HOFFER PB; KUNG HF; INNIS RB
      SPECT IMAGING OF STRIATAL DOPAMINE RELEASE AFTER AMPHETAMINE CHALLENGE

      The Journal of nuclear medicine
    79. ZEAPONCE Y; BALDWIN RM; LARUELLE M; WANG SY; NEUMEYER JL; INNIS RB
      SIMPLIFIED MULTIDOSE PREPARATION OF IODINE-123-BETA-CIT - A MARKER FOR DOPAMINE TRANSPORTERS

      The Journal of nuclear medicine
    80. ABIDARGHAM A; GANDELMAN M; ZOGHBI SS; LARUELLE M; BALDWIN RM; RANDALL P; ZEAPONCE Y; CHARNEY DS; HOFFER PB; INNIS RB
      REPRODUCIBILITY OF SPECT MEASUREMENT OF BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN WITH IODINE-123-IOMAZENIL

      The Journal of nuclear medicine
    81. MALISON RT; BEST SE; WALLACE EA; MCCANCE E; LARUELLE M; ZOGHBI SS; BALDWIN RM; SEIBYL JS; HOFFER PB; PRICE LH; KOSTEN TR; INNIS RB
      EUPHORIGENIC DOSES OF COCAINE REDUCE [I-123] BETA-CIT SPECT MEASURES OF DOPAMINE TRANSPORTER AVAILABILITY IN HUMAN COCAINE ADDICTS

      Psychopharmacology
    82. BALDWIN RM; ZEAPONCE Y; ZOGHBI SS; ALTIKRITI MS; SEIBYL JP; SYBIRSKA EH; MALISON RT; LARUELLE M; CHARNEY DS; HOFFER PB; INNIS RB
      PHARMACOKINETICS OF THE 3 RADIOIODINATED DOPAMINE D-2 RECEPTOR LIGANDS [I-123] IBF, [I-123] EPIDEPRIDE AND [I-123] 2'-ISP IN NONHUMAN-PRIMATES

      Nuclear medicine and biology
    83. ALTIKRITI MS; BALDWIN RM; ZEAPONCE Y; SYBIRSKA E; ZOGHBI SS; LARUELLE M; MALISON RT; KUNG HF; KESSLER RM; CHARNEY DS; HOFFER PB; INNIS RB
      COMPARISON OF 3 HIGH-AFFINITY SPECT RADIOTRACERS FOR THE DOPAMINE-D-2RECEPTOR

      Nuclear medicine and biology
    84. LARUELLE M; ABIDARGHAM A; VANDYCK CH; ALTIKRITI M; ZOGHBI S; ZEAPONCE Y; BALDWIN RM; CHARNEY DS; HOFFER PB; INNIS RB
      D-AMPHETAMINE INDUCED DISPLACEMENT OF [I-123] IBF EQUILIBRIUM BINDING- A SPECT PARADIGM TO EVALUATE DOPAMINE RELEASE

      Schizophrenia research
    85. ABIDARGHAM A; LARUELLE M; GANDELMAN M; ZOGHBI S; RANDALL P; SEIBYL J; BALDWIN RM; PONCE YZ; CHARNEY DS; HOFFER PB; INNIS RB
      SPECT IMAGING OF THE BENZODIAZEPINE RECEPTOR IN HUMANS USING [I-123] IOMAZENIL

      Schizophrenia research
    86. LARUELLE M; WALLACE E; SEIBYL JP; BALDWIN RM; ZEAPONCE Y; ZOGHBI SS; NEUMEYER JL; CHARNEY DS; HOFFER PB; INNIS RB
      GRAPHICAL, KINETIC, AND EQUILIBRIUM ANALYSES OF IN-VIVO [I-123] BETA-CIT BINDING TO DOPAMINE TRANSPORTERS IN HEALTHY-HUMAN SUBJECTS

      Journal of cerebral blood flow and metabolism
    87. LARUELLE M; BALDWIN RM; RATTNER Z; ALTIKRITI MS; ZEAPONCE Y; ZOGHBI SS; CHARNEY DS; PRICE JC; FROST JJ; HOFFER PB; INNIS RB
      SPECT QUANTIFICATION OF [I-123] IOMAZENIL BINDING TO BENZODIAZEPINE RECEPTORS IN NONHUMAN-PRIMATES .1. KINETIC MODELING OF SINGLE BOLUS EXPERIMENTS

      Journal of cerebral blood flow and metabolism
    88. LARUELLE M; ABIDARGHAM A; ALTIKRITI MS; BALDWIN RM; ZEAPONCE Y; ZOGHBI SS; CHARNEY DS; HOFFER PB; INNIS RB
      SPECT QUANTIFICATION OF [I-123] IOMAZENIL BINDING TO BENZODIAZEPINE RECEPTORS IN NONHUMAN-PRIMATES .2. EQUILIBRIUM-ANALYSIS OF CONSTANT INFUSION EXPERIMENTS AND CORRELATION WITH IN-VITRO PARAMETERS

      Journal of cerebral blood flow and metabolism
    89. LARUELLE M; ABIDARGHAM A; VANDYCK CH; ROSENBLAT W; ZOGHBI SS; ZEAPONCE Y; BALDWIN RM; CHARNEY DS; HOFFER PB; INNIS RB
      D-AMPHETAMINE INDUCED DOPAMINE RELEASE REDUCES THE BINDING POTENTIAL OF [I-123] IBF FOR DOPAMINE D2 D3 RECEPTORS IN HUMANS/

      The Journal of nuclear medicine
    90. LARUELLE M; WALLACE E; SEIBYL JP; BALDWIN RM; ZEAPONCE Y; ZOGHBI SS; NEUMEYER JL; CHARNEY DS; HOFFER PB; INNIS RB
      GRAPHICAL, KINETIC AND EQUILIBRIUM ANALYSES OF IN-VIVO [123I]BETA-CITBINDING TO DOPAMINE TRANSPORTERS IN HEALTHY-HUMAN

      The Journal of nuclear medicine
    91. GANDELMAN MS; SCANLEY BE; ALTIKRITI MS; LARUELLE M; ZEAPONCE Y; BALDWIN RM; ZOGHBI SS; CHARNEY DS; NEUMEYER JL; INNIS RB
      COMPARISON OF 2 I-123 LABELED SPECT PROBES, FOR THE DOPAMINE TRANSPORTER IN NONHUMAN PRIMATE BRAIN

      The Journal of nuclear medicine
    92. LARUELLE M; VANDYCK C; ABIDARGHAM A; ZEAPONCE Y; ZOGHBI SS; CHARNEY DS; BALDWIN RM; HOFFER PB; KUNG HF; INNIS RB
      COMPARTMENTAL MODELING OF IODINE-123-IODOBENZOFURAN BINDING TO DOPAMINE D2 RECEPTORS IN HEALTHY-SUBJECTS

      The Journal of nuclear medicine
    93. ABIDARGHAM A; LARUELLE M; SEIBYL J; RATTNER Z; BALDWIN RM; ZOGHBI SS; ZEAPONCE Y; BREMNER JD; HYDE TM; CHARNEY DS; HOFFER PB; INNIS RB
      SPECT MEASUREMENT OF BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN WITH IODINE-123-IOMAZENIL - KINETIC AND EQUILIBRIUM PARADIGMS

      The Journal of nuclear medicine
    94. MAREK KL; SEIBYL JP; SANDRIDGE B; FUSSELL B; SCANLEY BE; LARUELLE M; ABIDARGHAM A; WALLACE E; BALDWIN RM; ZEAPONCE Y; ZOGHBI S; CHARNEY DS; WANG S; GAO Y; NEUMEYER JL; HOFFER PB; INNIS RB
      SPECT IMAGING WITH [I-123] BETA-CIT DEMONSTRATES STRIATAL DOPAMINE TRANSPORTER LOSS IN PARKINSONISM

      Neurology
    95. SCANLEY BE; BALDWIN RM; LARUELLE M; ALTIKRITI MS; ZEAPONCE Y; ZOGHBI S; GIDDINGS SS; CHARNEY DS; HOFFER PB; WANG S; GAO Y; NEUMEYER JL; INNIS RB
      ACTIVE AND INACTIVE ENANTIOMERS OF 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE - COMPARISON USING HOMOGENATE BINDING AND SINGLE-PHOTONEMISSION COMPUTED TOMOGRAPHIC IMAGING

      Molecular pharmacology
    96. LARUELLE M; GIDDINGS SS; ZEAPONCE Y; CHARNEY DS; NEUMEYER JL; BALDWIN RM; INNIS RB
      METHYL TA-(4-[I-125]IODOPHENYL)TROPANE-2-BETA-CARBOXYLATE IN-VITRO BINDING TO DOPAMINE AND SEROTONIN TRANSPORTERS UNDER PHYSIOLOGICAL CONDITIONS

      Journal of neurochemistry
    97. LARUELLE M; ALTIKRITI MS; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; CHARNEY DS; HOFFER PB; KUNG HF; INNIS RB
      IN-VIVO QUANTIFICATION OF DOPAMINE D-2 RECEPTOR PARAMETERS IN NONHUMAN-PRIMATES WITH [I-123] IODOBENZOFURAN AND SINGLE-PHOTON EMISSION COMPUTERIZED-TOMOGRAPHY

      European journal of pharmacology
    98. LARUELLE M; ABIDARGHAM A; CASANOVA MF; WEINBERGER DR; KLEINMAN JE
      SEROTONIN(2A) RECEPTORS IN SCHIZOPHRENIA - RELATION TO SUICIDE - REPLY

      Archives of general psychiatry
    99. INNIS RB; SEIBYL JP; WALLACE E; SCANLEY E; LARUELLE M; ABIDARGHAM A; ZEAPONCE Y; ZOGHBI S; CHARNEY DS; WANG S; GAO Y; NEUMEYER JL; BALDWIN RM; MAREK K; HOFFER PB
      SPECT IMAGING DEMONSTRATES LOSS OF STRIATAL DOPAMINE TRANSPORTERS IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    100. LARUELLE M; VANDYCK CH; BRADBERRY CW; MALISON R; ALTIKRITI M; ZOGHBI SS; ZEAPONCE Y; BALDWIN RM; CHARNEY DS; HOFFER PB; INNIS RB
      DISPLACEMENT OF [I-123] IBF EQUILIBRIUM BINDING BY D-AMPHETAMINE TO MEASURE INVIVO DOPAMINE RELEASE

      The Journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 14:53:58